1. Home
  2. HPK vs KNSA Comparison

HPK vs KNSA Comparison

Compare HPK & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPK
  • KNSA
  • Stock Information
  • Founded
  • HPK 2019
  • KNSA 2015
  • Country
  • HPK United States
  • KNSA United Kingdom
  • Employees
  • HPK N/A
  • KNSA N/A
  • Industry
  • HPK Oil & Gas Production
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HPK Energy
  • KNSA Health Care
  • Exchange
  • HPK Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • HPK 1.6B
  • KNSA 1.7B
  • IPO Year
  • HPK N/A
  • KNSA 2018
  • Fundamental
  • Price
  • HPK $15.48
  • KNSA $21.09
  • Analyst Decision
  • HPK Hold
  • KNSA Strong Buy
  • Analyst Count
  • HPK 1
  • KNSA 5
  • Target Price
  • HPK $14.00
  • KNSA $36.60
  • AVG Volume (30 Days)
  • HPK 308.8K
  • KNSA 365.7K
  • Earning Date
  • HPK 11-04-2024
  • KNSA 10-29-2024
  • Dividend Yield
  • HPK 1.03%
  • KNSA N/A
  • EPS Growth
  • HPK N/A
  • KNSA N/A
  • EPS
  • HPK 1.26
  • KNSA N/A
  • Revenue
  • HPK $1,135,761,000.00
  • KNSA $384,098,000.00
  • Revenue This Year
  • HPK N/A
  • KNSA $60.05
  • Revenue Next Year
  • HPK N/A
  • KNSA $36.32
  • P/E Ratio
  • HPK $12.29
  • KNSA N/A
  • Revenue Growth
  • HPK 6.34
  • KNSA 54.41
  • 52 Week Low
  • HPK $12.20
  • KNSA $15.52
  • 52 Week High
  • HPK $17.48
  • KNSA $28.15
  • Technical
  • Relative Strength Index (RSI)
  • HPK 64.10
  • KNSA 34.36
  • Support Level
  • HPK $13.93
  • KNSA $20.41
  • Resistance Level
  • HPK $14.48
  • KNSA $21.55
  • Average True Range (ATR)
  • HPK 0.57
  • KNSA 0.87
  • MACD
  • HPK 0.20
  • KNSA -0.14
  • Stochastic Oscillator
  • HPK 93.02
  • KNSA 21.90

About HPK HighPeak Energy Inc.

HighPeak Energy Inc is an independent oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is oil and natural gas development, exploration, and production.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: